Safran Md Mph Elizabeth S is categorized under Internal Medicine Doctors in Alameda, CA and active since 2011.
Safran Md Mph Elizabeth S was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Elizabeth S Safran at the company’s single location by writing to 330 Westline Drive Apartment B421, Alameda, California CA 94501 or by phoning (973) 772-3078. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Safran Md Mph Elizabeth S |
| Contact Person: | Elizabeth S Safran |
| Address: | 330 Westline Drive Apartment B421, Alameda, California 94501 |
| Phone Number: | (973) 772-3078 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Safran Md Mph Elizabeth S was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Elizabeth S Safran for inquiries that concern Safran Md Mph Elizabeth S by calling the company number (973) 772-3078, as your correspondence is most welcome. Additionally, the physical location of the single location of Safran Md Mph Elizabeth S can be found at the coordinates as well as the street address 330 Westline Drive Apartment B421 in Alameda, California 94501.
For its online presence, you may visit Safran Md Mph Elizabeth S’s website at and engage with its social media outlets through on Twitter and on Facebook.